NEWS | March 17, 2023

St. Elizabeth Healthcare Invests $250,000 In Sense Neuro Diagnostics

Cincinnati MedTech Startup one of Eight Winners at 2022 Medical Innovation Challenge

CINCINNATI, OH – March 17, 2023 – Medical technology startup Sense Neuro Diagnostics has received $250,000 in  funding from St. Elizabeth Healthcare in Edgewood, Kentucky. The investment will help Sense Neuro Diagnostics as  the company advances clinical trials in its effort to commercialize a non-invasive technology to monitor traumatic  brain injuries. 

Sense Neuro Diagnostics is in the process of testing an innovative, non-invasive technology that can collect 360 data  points in 2.5 seconds to detect brain hemorrhage or stroke type. This technology has the potential to help first  responders, emergency department personnel, neuro ICU teams, and military field hospitals assess and monitor  traumatic brain injuries and assess different stroke types.  

“Innovation is one of our core values and at the root of so much that St. Elizabeth does,” says Sarah Giolando, senior  vice president and chief strategy officer, St. Elizabeth Healthcare. “We are pleased to partner with Sense Neuro  Diagnostics and help advance this novel technology with the goal of ultimately saving more lives in our hospitals and  across Northern Kentucky and Greater Cincinnati.” 

More than 20 sites across the United States, Canada, and India are currently engaged in pivotal trials to evaluate  Sense Neuro Diagnostics’ in-hospital device, and five sites are evaluating its military field device. 

“Our technology has the potential to be a total gamechanger for emergency rooms and hospital staff who treat  people with traumatic brain injuries and stokes every day,” says Geoff Klass, CEO, Sense Neuro Diagnostics. “Sense  Neuro Diagnostics is grateful for this partnership with St. Elizabeth Healthcare and we can’t wait until their talented  medical professionals can apply this technology to their care first-hand.” 

Behind the Science: Non-Invasive Brain Scanners

Time is brain. You’ll hear us say that a lot at Sense Neuro Diagnostics. We’re on a mission to aid personnel to detect, monitor, and manage brain conditions in real-time. Once a brain cell dies, there’s no getting it back. If you or a loved one is riding in an ambulance going to a hospital ill-prepared for a brain injury or waiting in the ER for a CT scan, those could be crucial moments slipping away that you’ll never get back, possibly resulting in permanent disability or death.

Sense Neuro Welcomes Eric Bailey as Chief Commercial Officer

Cincinnati, OH - Sense Neuro Diagnostics today announced the hiring of Eric Bailey as Chief Commercial Officer. With experience as a seasoned CEO and expertise in technical and operational responsibilities in startup businesses, specifically in the market areas Sense Neuro intends to enter, we are proud to welcome Bailey to the team.

US FDA New Clinical for Sense Neuro Diagnostics

The new trial approved by the FDA Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices will begin as soon as June 2023 and involve up to 300 patients at 30 sites in the United States, as well as Canada and India.

Sense Neuro Diagnostics Places Second In Unicorn Cup Finals Q4 2022

Cincinnati-based Sense Neuro Diagnostics is pursuing new international investment opportunities after coming in second place in the Unicorn CUP Finals startup competition. The pitch event is affiliated with Unicorn Events, the world’s largest startup pitch competition that focuses on discovering extraordinary startups that have the potential to achieve a valuation of $1 billion or more.